Diacylglycerol	B:C1743812
Kinase	I:C1743812
ζ	I:C1743812
Limits	O
Cytokine	O
-	O
dependent	O
Expansion	O
of	O
CD8	O
(+)	I:C0242629

Diacylglycerol	O
Kinase	I:C1743812
ζ	I:C1743812
Limits	O
Cytokine	B:C0079189
-	O
dependent	O
Expansion	O
of	O
CD8	O
(+)	I:C0242629

Diacylglycerol	O
Kinase	I:C1743812
ζ	I:C1743812
Limits	O
Cytokine	O
-	O
dependent	O
Expansion	B:C0007595
of	O
CD8	O
(+)	I:C0242629

Diacylglycerol	O
Kinase	I:C1743812
ζ	I:C1743812
Limits	O
Cytokine	O
-	O
dependent	O
Expansion	O
of	O
CD8	B:C0242629
(+)	I:C0242629

T	I:C0242629
Cells	I:C0242629
with	O
Broad	O
Antitumor	B:C0243095
Capacity	I:C0243095
Interleukin	O
-	I:C0021756
2	I:C0021756
and	O
-	O
15	I:C0254610
drive	O
expansion	O
/	O
differentiation	O
of	O
cytotoxic	O
CD8	I:C0039195
(+)	I:C0039195

T	I:C0242629
Cells	I:C0242629
with	O
Broad	O
Antitumor	O
Capacity	I:C0243095
Interleukin	B:C0021756
-	I:C0021756
2	I:C0021756
and	O
-	O
15	I:C0254610
drive	O
expansion	O
/	O
differentiation	O
of	O
cytotoxic	O
CD8	I:C0039195
(+)	I:C0039195

T	I:C0242629
Cells	I:C0242629
with	O
Broad	O
Antitumor	O
Capacity	I:C0243095
Interleukin	O
-	I:C0021756
2	I:C0021756
and	O
-	B:C0254610
15	I:C0254610
drive	O
expansion	O
/	O
differentiation	O
of	O
cytotoxic	O
CD8	I:C0039195
(+)	I:C0039195

T	I:C0242629
Cells	I:C0242629
with	O
Broad	O
Antitumor	O
Capacity	I:C0243095
Interleukin	O
-	I:C0021756
2	I:C0021756
and	O
-	O
15	I:C0254610
drive	O
expansion	B:C0007595
/	O
differentiation	O
of	O
cytotoxic	O
CD8	I:C0039195
(+)	I:C0039195

T	I:C0242629
Cells	I:C0242629
with	O
Broad	O
Antitumor	O
Capacity	I:C0243095
Interleukin	O
-	I:C0021756
2	I:C0021756
and	O
-	O
15	I:C0254610
drive	O
expansion	O
/	O
differentiation	B:C0007589
of	O
cytotoxic	O
CD8	I:C0039195
(+)	I:C0039195

T	I:C0242629
Cells	I:C0242629
with	O
Broad	O
Antitumor	O
Capacity	I:C0243095
Interleukin	O
-	I:C0021756
2	I:C0021756
and	O
-	O
15	I:C0254610
drive	O
expansion	O
/	O
differentiation	O
of	O
cytotoxic	B:C0039195
CD8	I:C0039195
(+)	I:C0039195

T	I:C0039195
cells	I:C0039195
that	O
eliminate	O
targets	O
via	O
antigen	B:C0599733
-	I:C0599733
independent	I:C0599733
killing	I:C0599733
.	O

This	O
property	O
is	O
clinically	O
relevant	O
for	O
the	O
improvement	O
of	O
T	B:C0242629
cell	I:C0242629
-	O
based	O
antitumor	O
therapies	I:C0087111
.	O

This	O
property	O
is	O
clinically	O
relevant	O
for	O
the	O
improvement	O
of	O
T	O
cell	I:C0242629
-	O
based	O
antitumor	B:C0087111
therapies	I:C0087111
.	O

Diacylglycerol	B:C3815868
kinase	I:C3815868
α	I:C3815868
and	O
ζ	O
(	O
DGKα	O
/	O
ζ	O
)	O
metabolize	O
the	O
diacylglycerol	O
generated	O
following	O
antigen	O
recognition	O
by	O
T	O
lymphocytes	I:C0242629
.	O

Diacylglycerol	O
kinase	I:C3815868
α	I:C3815868
and	O
ζ	B:C1743812
(	O
DGKα	O
/	O
ζ	O
)	O
metabolize	O
the	O
diacylglycerol	O
generated	O
following	O
antigen	O
recognition	O
by	O
T	O
lymphocytes	I:C0242629
.	O

Diacylglycerol	O
kinase	I:C3815868
α	I:C3815868
and	O
ζ	O
(	O
DGKα	B:C3815868
/	O
ζ	O
)	O
metabolize	O
the	O
diacylglycerol	O
generated	O
following	O
antigen	O
recognition	O
by	O
T	O
lymphocytes	I:C0242629
.	O

Diacylglycerol	O
kinase	I:C3815868
α	I:C3815868
and	O
ζ	O
(	O
DGKα	O
/	O
ζ	B:C1743812
)	O
metabolize	O
the	O
diacylglycerol	O
generated	O
following	O
antigen	O
recognition	O
by	O
T	O
lymphocytes	I:C0242629
.	O

Diacylglycerol	O
kinase	I:C3815868
α	I:C3815868
and	O
ζ	O
(	O
DGKα	O
/	O
ζ	O
)	O
metabolize	B:C1148560
the	O
diacylglycerol	O
generated	O
following	O
antigen	O
recognition	O
by	O
T	O
lymphocytes	I:C0242629
.	O

Diacylglycerol	O
kinase	I:C3815868
α	I:C3815868
and	O
ζ	O
(	O
DGKα	O
/	O
ζ	O
)	O
metabolize	O
the	O
diacylglycerol	B:C0043791
generated	O
following	O
antigen	O
recognition	O
by	O
T	O
lymphocytes	I:C0242629
.	O

Diacylglycerol	O
kinase	I:C3815868
α	I:C3815868
and	O
ζ	O
(	O
DGKα	O
/	O
ζ	O
)	O
metabolize	O
the	O
diacylglycerol	O
generated	O
following	O
antigen	O
recognition	O
by	O
T	B:C0242629
lymphocytes	I:C0242629
.	O

Enhanced	O
expression	B:C1171362
of	O
these	O
two	O
lipid	O
kinases	I:C0113519
in	O
tumor	O
-	I:C0079722
infiltrating	I:C0079722
CD8	I:C0079722
(+	I:C0079722
)	I:C0079722

Enhanced	O
expression	O
of	O
these	O
two	O
lipid	B:C0113519
kinases	I:C0113519
in	O
tumor	O
-	I:C0079722
infiltrating	I:C0079722
CD8	I:C0079722
(+	I:C0079722
)	I:C0079722

Enhanced	O
expression	O
of	O
these	O
two	O
lipid	O
kinases	I:C0113519
in	O
tumor	B:C0079722
-	I:C0079722
infiltrating	I:C0079722
CD8	I:C0079722
(+	I:C0079722
)	I:C0079722

T	I:C0079722
cells	I:C0079722
promotes	O
a	O
hyporesponsive	O
state	O
that	O
contributes	O
to	O
tumor	B:C0282683
immune	I:C0282683
escape	I:C0282683
.	O

Inhibition	B:C1524081
of	O
these	O
two	O
enzymes	O
might	O
thus	O
be	O
of	O
interest	O
for	O
potentiating	O
conventional	O
antigen	O
-	O
directed	O
tumor	O
elimination	O
.	O

Inhibition	O
of	O
these	O
two	O
enzymes	B:C0014442
might	O
thus	O
be	O
of	O
interest	O
for	O
potentiating	O
conventional	O
antigen	O
-	O
directed	O
tumor	O
elimination	O
.	O

Inhibition	O
of	O
these	O
two	O
enzymes	O
might	O
thus	O
be	O
of	O
interest	O
for	O
potentiating	O
conventional	O
antigen	B:C0003320
-	O
directed	O
tumor	O
elimination	O
.	O

Inhibition	O
of	O
these	O
two	O
enzymes	O
might	O
thus	O
be	O
of	O
interest	O
for	O
potentiating	O
conventional	O
antigen	O
-	O
directed	O
tumor	B:C0027651
elimination	O
.	O

Inhibition	O
of	O
these	O
two	O
enzymes	O
might	O
thus	O
be	O
of	O
interest	O
for	O
potentiating	O
conventional	O
antigen	O
-	O
directed	O
tumor	O
elimination	B:C3178995
.	O

In	O
this	O
study	O
,	O
we	O
sought	O
to	O
characterize	O
the	O
contribution	O
of	O
DGKα	B:C3815868
and	O
ζ	O
to	O
antigen	O
-	O
independent	O
cytotoxic	O
functions	O
of	O
CD8	O
(+	I:C0242629
)	I:C0242629

In	O
this	O
study	O
,	O
we	O
sought	O
to	O
characterize	O
the	O
contribution	O
of	O
DGKα	O
and	O
ζ	B:C1743812
to	O
antigen	O
-	O
independent	O
cytotoxic	O
functions	O
of	O
CD8	O
(+	I:C0242629
)	I:C0242629

In	O
this	O
study	O
,	O
we	O
sought	O
to	O
characterize	O
the	O
contribution	O
of	O
DGKα	O
and	O
ζ	O
to	O
antigen	B:C0003320
-	O
independent	O
cytotoxic	O
functions	O
of	O
CD8	O
(+	I:C0242629
)	I:C0242629

In	O
this	O
study	O
,	O
we	O
sought	O
to	O
characterize	O
the	O
contribution	O
of	O
DGKα	O
and	O
ζ	O
to	O
antigen	O
-	O
independent	O
cytotoxic	O
functions	O
of	O
CD8	B:C0242629
(+	I:C0242629
)	I:C0242629

Analysis	B:C0936012
of	O
DGK	O
ζ	I:C1743812
-	O
deficient	O
mice	O
showed	O
an	O
increase	O
in	O
bystander	O
memory	I:C0949629
-	O
like	O
CD8	O
(	I:C0242629
+	I:C0242629
)	I:C0242629

Analysis	O
of	O
DGK	B:C1743812
ζ	I:C1743812
-	O
deficient	O
mice	O
showed	O
an	O
increase	O
in	O
bystander	O
memory	I:C0949629
-	O
like	O
CD8	O
(	I:C0242629
+	I:C0242629
)	I:C0242629

Analysis	O
of	O
DGK	O
ζ	I:C1743812
-	O
deficient	O
mice	B:C0025929
showed	O
an	O
increase	O
in	O
bystander	O
memory	I:C0949629
-	O
like	O
CD8	O
(	I:C0242629
+	I:C0242629
)	I:C0242629

Analysis	O
of	O
DGK	O
ζ	I:C1743812
-	O
deficient	O
mice	O
showed	O
an	O
increase	O
in	O
bystander	B:C0949629
memory	I:C0949629
-	O
like	O
CD8	O
(	I:C0242629
+	I:C0242629
)	I:C0242629

Analysis	O
of	O
DGK	O
ζ	I:C1743812
-	O
deficient	O
mice	O
showed	O
an	O
increase	O
in	O
bystander	O
memory	I:C0949629
-	O
like	O
CD8	B:C0242629
(	I:C0242629
+	I:C0242629
)	I:C0242629

T	I:C0242629
cell	I:C0242629
populations	I:C0242629
not	O
observed	O
in	O
DGKα	B:C3815868
-	O
deficient	O
mice	O
.	O

T	I:C0242629
cell	I:C0242629
populations	I:C0242629
not	O
observed	O
in	O
DGKα	O
-	O
deficient	O
mice	B:C0025929
.	O

We	O
demonstrate	O
that	O
DGK	B:C1743812
ζ	I:C1743812
limits	O
cytokine	O
responses	I:C2247677
in	O
an	O
antigen	O
-	O
independent	O
manner	O
.	O

We	O
demonstrate	O
that	O
DGK	O
ζ	I:C1743812
limits	O
cytokine	B:C2247677
responses	I:C2247677
in	O
an	O
antigen	O
-	O
independent	O
manner	O
.	O

We	O
demonstrate	O
that	O
DGK	O
ζ	I:C1743812
limits	O
cytokine	O
responses	I:C2247677
in	O
an	O
antigen	B:C0003320
-	O
independent	O
manner	O
.	O

Cytokine	B:C0079189
-	O
specific	O
expansion	O
of	O
DGK	O
ζ	I:C1743812
-	O
deficient	O
CD8	O
(+)	I:C0242629

Cytokine	O
-	O
specific	O
expansion	B:C0007595
of	O
DGK	O
ζ	I:C1743812
-	O
deficient	O
CD8	O
(+)	I:C0242629

Cytokine	O
-	O
specific	O
expansion	O
of	O
DGK	B:C1743812
ζ	I:C1743812
-	O
deficient	O
CD8	O
(+)	I:C0242629

Cytokine	O
-	O
specific	O
expansion	O
of	O
DGK	O
ζ	I:C1743812
-	O
deficient	O
CD8	B:C0242629
(+)	I:C0242629

T	I:C0242629
cells	I:C0242629
promoted	O
enhanced	O
differentiation	B:C0007589
of	O
innate	O
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
cells	I:C0039195
in	O
vitro	O
,	O
and	O
correlated	O
with	O
the	O
more	O
potent	O
in	O
vivo	I:C1515655
anti-tumor	O
responses	I:C0243095
of	O
DGK	O
ζ	I:C1743812
-	O
deficient	O
mice	O
engrafted	O
with	O
the	O
murine	O
A20	I:C0026809
lymphoma	O
.	O

T	I:C0242629
cells	I:C0242629
promoted	O
enhanced	O
differentiation	O
of	O
innate	B:C0039195
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
cells	I:C0039195
in	O
vitro	O
,	O
and	O
correlated	O
with	O
the	O
more	O
potent	O
in	O
vivo	I:C1515655
anti-tumor	O
responses	I:C0243095
of	O
DGK	O
ζ	I:C1743812
-	O
deficient	O
mice	O
engrafted	O
with	O
the	O
murine	O
A20	I:C0026809
lymphoma	O
.	O

T	I:C0242629
cells	I:C0242629
promoted	O
enhanced	O
differentiation	O
of	O
innate	O
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
cells	I:C0039195
in	O
vitro	O
,	O
and	O
correlated	O
with	O
the	O
more	O
potent	O
in	B:C1515655
vivo	I:C1515655
anti-tumor	O
responses	I:C0243095
of	O
DGK	O
ζ	I:C1743812
-	O
deficient	O
mice	O
engrafted	O
with	O
the	O
murine	O
A20	I:C0026809
lymphoma	O
.	O

T	I:C0242629
cells	I:C0242629
promoted	O
enhanced	O
differentiation	O
of	O
innate	O
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
cells	I:C0039195
in	O
vitro	O
,	O
and	O
correlated	O
with	O
the	O
more	O
potent	O
in	O
vivo	I:C1515655
anti-tumor	B:C0243095
responses	I:C0243095
of	O
DGK	O
ζ	I:C1743812
-	O
deficient	O
mice	O
engrafted	O
with	O
the	O
murine	O
A20	I:C0026809
lymphoma	O
.	O

T	I:C0242629
cells	I:C0242629
promoted	O
enhanced	O
differentiation	O
of	O
innate	O
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
cells	I:C0039195
in	O
vitro	O
,	O
and	O
correlated	O
with	O
the	O
more	O
potent	O
in	O
vivo	I:C1515655
anti-tumor	O
responses	I:C0243095
of	O
DGK	B:C1743812
ζ	I:C1743812
-	O
deficient	O
mice	O
engrafted	O
with	O
the	O
murine	O
A20	I:C0026809
lymphoma	O
.	O

T	I:C0242629
cells	I:C0242629
promoted	O
enhanced	O
differentiation	O
of	O
innate	O
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
cells	I:C0039195
in	O
vitro	O
,	O
and	O
correlated	O
with	O
the	O
more	O
potent	O
in	O
vivo	I:C1515655
anti-tumor	O
responses	I:C0243095
of	O
DGK	O
ζ	I:C1743812
-	O
deficient	O
mice	B:C0025929
engrafted	O
with	O
the	O
murine	O
A20	I:C0026809
lymphoma	O
.	O

T	I:C0242629
cells	I:C0242629
promoted	O
enhanced	O
differentiation	O
of	O
innate	O
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
cells	I:C0039195
in	O
vitro	O
,	O
and	O
correlated	O
with	O
the	O
more	O
potent	O
in	O
vivo	I:C1515655
anti-tumor	O
responses	I:C0243095
of	O
DGK	O
ζ	I:C1743812
-	O
deficient	O
mice	O
engrafted	O
with	O
the	O
murine	B:C0026809
A20	I:C0026809
lymphoma	O
.	O

T	I:C0242629
cells	I:C0242629
promoted	O
enhanced	O
differentiation	O
of	O
innate	O
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
cells	I:C0039195
in	O
vitro	O
,	O
and	O
correlated	O
with	O
the	O
more	O
potent	O
in	O
vivo	I:C1515655
anti-tumor	O
responses	I:C0243095
of	O
DGK	O
ζ	I:C1743812
-	O
deficient	O
mice	O
engrafted	O
with	O
the	O
murine	O
A20	I:C0026809
lymphoma	B:C0024299
.	O

Our	O
studies	O
reveal	O
a	O
isoform	B:C0597298
-	O
specific	O
function	O
for	O
DGK	O
ζ	I:C1743812
downstream	O
of	O
IL	O
-	I:C0021756
2	I:C0021756
/	O
IL	O
-	I:C0254610
15	I:C0254610
-	O
mediated	O
expansion	O
of	O
innate	O
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
T	I:C0039195
cells	I:C0039195
,	O
Pharmacological	O
manipulation	O
of	O
DGK	O
ζ	I:C1743812
activity	O
is	O
of	O
therapeutic	O
interest	O
for	O
cytokine	O
-	O
directed	O
anti-tumor	O
treatments	I:C0087111
.	O

Our	O
studies	O
reveal	O
a	O
isoform	O
-	O
specific	O
function	O
for	O
DGK	B:C1743812
ζ	I:C1743812
downstream	O
of	O
IL	O
-	I:C0021756
2	I:C0021756
/	O
IL	O
-	I:C0254610
15	I:C0254610
-	O
mediated	O
expansion	O
of	O
innate	O
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
T	I:C0039195
cells	I:C0039195
,	O
Pharmacological	O
manipulation	O
of	O
DGK	O
ζ	I:C1743812
activity	O
is	O
of	O
therapeutic	O
interest	O
for	O
cytokine	O
-	O
directed	O
anti-tumor	O
treatments	I:C0087111
.	O

Our	O
studies	O
reveal	O
a	O
isoform	O
-	O
specific	O
function	O
for	O
DGK	O
ζ	I:C1743812
downstream	B:C0522506
of	O
IL	O
-	I:C0021756
2	I:C0021756
/	O
IL	O
-	I:C0254610
15	I:C0254610
-	O
mediated	O
expansion	O
of	O
innate	O
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
T	I:C0039195
cells	I:C0039195
,	O
Pharmacological	O
manipulation	O
of	O
DGK	O
ζ	I:C1743812
activity	O
is	O
of	O
therapeutic	O
interest	O
for	O
cytokine	O
-	O
directed	O
anti-tumor	O
treatments	I:C0087111
.	O

Our	O
studies	O
reveal	O
a	O
isoform	O
-	O
specific	O
function	O
for	O
DGK	O
ζ	I:C1743812
downstream	O
of	O
IL	B:C0021756
-	I:C0021756
2	I:C0021756
/	O
IL	O
-	I:C0254610
15	I:C0254610
-	O
mediated	O
expansion	O
of	O
innate	O
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
T	I:C0039195
cells	I:C0039195
,	O
Pharmacological	O
manipulation	O
of	O
DGK	O
ζ	I:C1743812
activity	O
is	O
of	O
therapeutic	O
interest	O
for	O
cytokine	O
-	O
directed	O
anti-tumor	O
treatments	I:C0087111
.	O

Our	O
studies	O
reveal	O
a	O
isoform	O
-	O
specific	O
function	O
for	O
DGK	O
ζ	I:C1743812
downstream	O
of	O
IL	O
-	I:C0021756
2	I:C0021756
/	O
IL	B:C0254610
-	I:C0254610
15	I:C0254610
-	O
mediated	O
expansion	O
of	O
innate	O
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
T	I:C0039195
cells	I:C0039195
,	O
Pharmacological	O
manipulation	O
of	O
DGK	O
ζ	I:C1743812
activity	O
is	O
of	O
therapeutic	O
interest	O
for	O
cytokine	O
-	O
directed	O
anti-tumor	O
treatments	I:C0087111
.	O

Our	O
studies	O
reveal	O
a	O
isoform	O
-	O
specific	O
function	O
for	O
DGK	O
ζ	I:C1743812
downstream	O
of	O
IL	O
-	I:C0021756
2	I:C0021756
/	O
IL	O
-	I:C0254610
15	I:C0254610
-	O
mediated	O
expansion	B:C0007595
of	O
innate	O
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
T	I:C0039195
cells	I:C0039195
,	O
Pharmacological	O
manipulation	O
of	O
DGK	O
ζ	I:C1743812
activity	O
is	O
of	O
therapeutic	O
interest	O
for	O
cytokine	O
-	O
directed	O
anti-tumor	O
treatments	I:C0087111
.	O

Our	O
studies	O
reveal	O
a	O
isoform	O
-	O
specific	O
function	O
for	O
DGK	O
ζ	I:C1743812
downstream	O
of	O
IL	O
-	I:C0021756
2	I:C0021756
/	O
IL	O
-	I:C0254610
15	I:C0254610
-	O
mediated	O
expansion	O
of	O
innate	B:C0039195
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
T	I:C0039195
cells	I:C0039195
,	O
Pharmacological	O
manipulation	O
of	O
DGK	O
ζ	I:C1743812
activity	O
is	O
of	O
therapeutic	O
interest	O
for	O
cytokine	O
-	O
directed	O
anti-tumor	O
treatments	I:C0087111
.	O

Our	O
studies	O
reveal	O
a	O
isoform	O
-	O
specific	O
function	O
for	O
DGK	O
ζ	I:C1743812
downstream	O
of	O
IL	O
-	I:C0021756
2	I:C0021756
/	O
IL	O
-	I:C0254610
15	I:C0254610
-	O
mediated	O
expansion	O
of	O
innate	O
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
T	I:C0039195
cells	I:C0039195
,	O
Pharmacological	O
manipulation	B:C0947647
of	O
DGK	O
ζ	I:C1743812
activity	O
is	O
of	O
therapeutic	O
interest	O
for	O
cytokine	O
-	O
directed	O
anti-tumor	O
treatments	I:C0087111
.	O

Our	O
studies	O
reveal	O
a	O
isoform	O
-	O
specific	O
function	O
for	O
DGK	O
ζ	I:C1743812
downstream	O
of	O
IL	O
-	I:C0021756
2	I:C0021756
/	O
IL	O
-	I:C0254610
15	I:C0254610
-	O
mediated	O
expansion	O
of	O
innate	O
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
T	I:C0039195
cells	I:C0039195
,	O
Pharmacological	O
manipulation	O
of	O
DGK	B:C1743812
ζ	I:C1743812
activity	O
is	O
of	O
therapeutic	O
interest	O
for	O
cytokine	O
-	O
directed	O
anti-tumor	O
treatments	I:C0087111
.	O

Our	O
studies	O
reveal	O
a	O
isoform	O
-	O
specific	O
function	O
for	O
DGK	O
ζ	I:C1743812
downstream	O
of	O
IL	O
-	I:C0021756
2	I:C0021756
/	O
IL	O
-	I:C0254610
15	I:C0254610
-	O
mediated	O
expansion	O
of	O
innate	O
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
T	I:C0039195
cells	I:C0039195
,	O
Pharmacological	O
manipulation	O
of	O
DGK	O
ζ	I:C1743812
activity	B:C0243102
is	O
of	O
therapeutic	O
interest	O
for	O
cytokine	O
-	O
directed	O
anti-tumor	O
treatments	I:C0087111
.	O

Our	O
studies	O
reveal	O
a	O
isoform	O
-	O
specific	O
function	O
for	O
DGK	O
ζ	I:C1743812
downstream	O
of	O
IL	O
-	I:C0021756
2	I:C0021756
/	O
IL	O
-	I:C0254610
15	I:C0254610
-	O
mediated	O
expansion	O
of	O
innate	O
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
T	I:C0039195
cells	I:C0039195
,	O
Pharmacological	O
manipulation	O
of	O
DGK	O
ζ	I:C1743812
activity	O
is	O
of	O
therapeutic	O
interest	O
for	O
cytokine	B:C0079189
-	O
directed	O
anti-tumor	O
treatments	I:C0087111
.	O

Our	O
studies	O
reveal	O
a	O
isoform	O
-	O
specific	O
function	O
for	O
DGK	O
ζ	I:C1743812
downstream	O
of	O
IL	O
-	I:C0021756
2	I:C0021756
/	O
IL	O
-	I:C0254610
15	I:C0254610
-	O
mediated	O
expansion	O
of	O
innate	O
-	I:C0039195
like	I:C0039195
cytotoxic	I:C0039195
T	I:C0039195
cells	I:C0039195
,	O
Pharmacological	O
manipulation	O
of	O
DGK	O
ζ	I:C1743812
activity	O
is	O
of	O
therapeutic	O
interest	O
for	O
cytokine	O
-	O
directed	O
anti-tumor	B:C0087111
treatments	I:C0087111
.	O

